Skip to content

One-anastomosis Gastric Bypass/Mini-Gastric Bypass Versus Roux-en Y Gastric Bypass

The Evidence of One-anastomosis Gastric Bypass/Mini-Gastric Bypass Versus Roux-en Y Gastric Bypass in Metabolic Surgery - a Prospective Randomized Controlled Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03045679
Acronym
MGBvsRYGB
Enrollment
100
Registered
2017-02-07
Start date
2018-01-01
Completion date
2020-12-01
Last updated
2023-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Roux-en Y gastric bypass, One-anastomosis gastric bypass, Mini-gastric bypass, metabolic surgery

Brief summary

The aim of this prospective randomized controlled trial is to compare the two procedures One-anastomosis gastric Bypass/Mini-gastric Bypass (OAGB/MGB) and Roux-en Y gastric bypass (RYGB) in relation to intraoperative and postoperative complications (classification of Clavien-Dindo), mortality, metabolic impact (remission of type 2 diabetes mellitus, hypertonus, gastro-esophageal reflux disease, sleep apnea, dyslipidemia, quality of life, operation time, postoperative excess weight loss, malnutrition and re-do/revisonal surgery.

Detailed description

OAGB/MGB is gaining popularity as a primary surgical treatment for morbid obesity due to reduced operation time, a shorter learning curve, better weight loss, higher metabolic impact and fewer major complications compared to RYGB. In this prospective randomized controlled trial we want to compare OAGB/MGB and RYGB with a FU of up to 24 month. Patients with indication for gastric bypass get randomized in group A (RYGB, n = 50) or B (OAGB/MGB, n = 50). FU is performed 1, 3, 6, 12 and 24 month after surgery.

Interventions

OTHERRYGB

laparoscopic RYGB

OTHEROAGB/MGB

laparoscopic OAGB/MGB

Sponsors

Sana Klinikum Offenbach
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

envelope randomization

Intervention model description

prospective randomized controlled trial: RYGB (group A) vs OAGB/MGB (group B)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. primary obesity surgery and indication for gastric bypass 2. age: 18 - 65 years 3. BMI \> 40 kg/m² or BMI \> 35 kg/m² with obesity related comorbidities 4. informed consent

Exclusion criteria

1. obesity surgery in the anamnesis 2. visceral surgery in the anamnesis (excluding appendectomy and cholecystectomy)

Design outcomes

Primary

MeasureTime frameDescription
complicationsup to 2 years after surgerycomplications classified next to Clavien-Dindo

Secondary

MeasureTime frameDescription
remission of type 2 diabetes mellitusup to 2 years after surgeryHbA1c \< 6.5% without medication
remission of hypertonusup to 2 years after surgeryblood pressure \< 140/90 mmHg without medication
gastro-esophageal reflux diseaseup to 2 years after surgeryGERD-HRGL Heartburn Scale
remission of sleep apneaup to 2 years after surgerypresence/absence of CPAP
remission of hypertrigliceridemiaup to 2 years after surgerytriglyceride \< 200mg/dl without medication
remission of hypercholesterinemiaup to 2 years after surgerycholesterin \< 155 mg/dl without medication
quality of life questionnaireup to 2 years after surgerychanging in quality of life measured by questionnaire
weight lossup to 2 years after surgerypostoperative excess weight loss in %
operation timeoperation time during surgery in minutesoperation time during surgery in minutes
mortalityup to 2 years after surgerydeath up to 2 years after surgery
malnutrition 2up to 2 years after surgerypostoperative malnutrition: albumin \< 35 g/l
malnutrition 3up to 2 years after surgerypostoperative malnutrition: ferritin (\< 30 µg/l)
malnutrition 4up to 2 years after surgerypostoperative malnutrition: vitamin E \< 12 µmol/l
malnutrition 5up to 2 years after surgerypostoperative malnutrition: vitamin K \< 90 ng/l
malnutrition 6up to 2 years after surgerypostoperative malnutrition: vitamin 25-OH- Vitamin D3 \< 50 nmol/l
malnutrition 7up to 2 years after surgerypostoperative malnutrition: vitamin A \< 1.05 µmol/l
malnutrition 8up to 2 years after surgerypostoperative malnutrition: vitamin B12 \< 145 pmol/l
revisional surgeryup to 2 years after surgeryrevisional surgery during follow up
malnutrition 1up to 2 years after surgerypostoperative malnutrition: protein \< 64 g/l

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026